VERA THERAPEUTICS INC's ticker is VERA and the CUSIP is 92337R101. A total of 60 filers reported holding VERA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,134,661 | -14.6% | 301,580 | 0.0% | 0.27% | +2.3% |
| Q2 2023 | $4,840,359 | +106.8% | 301,580 | 0.0% | 0.26% | +100.0% |
| Q1 2023 | $2,340,261 | -59.9% | 301,580 | 0.0% | 0.13% | -61.7% |
| Q4 2022 | $5,835,573 | -9.2% | 301,580 | 0.0% | 0.34% | +3.4% |
| Q3 2022 | $6,427,000 | +56.6% | 301,580 | 0.0% | 0.33% | +47.1% |
| Q2 2022 | $4,105,000 | -42.1% | 301,580 | 0.0% | 0.22% | -3.0% |
| Q1 2022 | $7,084,000 | -62.9% | 301,580 | -57.7% | 0.23% | -50.0% |
| Q4 2021 | $19,069,000 | +16.3% | 713,658 | -24.5% | 0.46% | +18.3% |
| Q3 2021 | $16,392,000 | +30.8% | 944,791 | 0.0% | 0.39% | +52.5% |
| Q2 2021 | $12,528,000 | – | 944,791 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 5,450,000 | $74,719,500 | 8.73% |
| Kynam Capital Management, LP | 2,956,053 | $40,527,487 | 6.63% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 758,355 | $10,381,880 | 3.50% |
| Sofinnova Investments, Inc. | 3,467,156 | $47,534,709 | 3.00% |
| Altium Capital Management LP | 333,681 | $4,574,767 | 2.39% |
| Eversept Partners, LP | 1,478,489 | $20,270,084 | 1.72% |
| SECTORAL ASSET MANAGEMENT INC | 357,139 | $4,896,376 | 0.95% |
| Carlyle Group Inc. | 1,438,155 | $19,688,342 | 0.85% |
| Orbimed Advisors | 1,518,115 | $20,813,357 | 0.44% |
| Woodline Partners LP | 2,562,600 | $35,133,246 | 0.41% |